Align Glutamine synthetase; GS; Glutamate--ammonia ligase; Glutamine synthetase III; GSIII; EC 6.3.1.2 (characterized)
to candidate WP_019556640.1 F612_RS0104905 type III glutamate--ammonia ligase
Query= SwissProt::O87393 (435 letters) >NCBI__GCF_000381085.1:WP_019556640.1 Length = 453 Score = 325 bits (834), Expect = 1e-93 Identities = 177/435 (40%), Positives = 258/435 (59%), Gaps = 20/435 (4%) Query: 10 REKGVKYFMISYTDLFGGQRAKLVPAEAIADMQKGGAGFAGFAT-WFDLTPAHPDLFALP 68 + KGVKY + +Y D+ G + K VP + M KG + G+A P ++ ++P Sbjct: 15 KAKGVKYCLGAYVDIHGIPKGKFVPIDHFPQMVKGSELYTGYAVDGLGQKPNEDEIASVP 74 Query: 69 DASAVIQLPWKKDVAWVAADCIMDDAPVEQAPRVVLKKLVAEAAQEGLRVKTGVEPEFFL 128 D +++IQLPW+ +VAW+AAD + P + RV LKK++AEAA+ G G+E E F+ Sbjct: 75 DLNSLIQLPWQPEVAWMAADNTLHGEPYDINTRVALKKVLAEAAEMGFGFNLGIECELFV 134 Query: 129 ISP--DGS-KISDTFDTAEKPCYDQQAIMRRYDVIAEICDYMLELGWKPYQNDHEDANGQ 185 + DGS I D D KPCYD + M R+ I ++ + +LGW Y DHEDANGQ Sbjct: 135 VKEEADGSLSIPDKNDNLTKPCYDVSSFMNRFTWIDKMATTIDDLGWDLYSLDHEDANGQ 194 Query: 186 FEMNWEYDDALRTADKHSFFKFMVKSIAEKHGLRATFMPKPFKGLTGNGCHCHISVWDLA 245 +E +++Y DAL D+ FF++M K A + GL AT MPKPF TGNG H ++S++DL Sbjct: 195 YEFDFKYSDALTMCDRFIFFRYMAKHYAAEEGLLATMMPKPFADKTGNGAHFNMSLFDLE 254 Query: 246 GEVNAF----ADNKAEFGLSAEGRHFLGGIMKHASALAAVTNPTVNSYKRINAPRTISGA 301 + N F D+ GL+ G HF+ G++KH AL AV +PTVNSYKR+ ++ Sbjct: 255 SKENLFEYDPKDDPRGLGLTEIGYHFIAGVLKHGPALCAVFSPTVNSYKRLVRQGDMATF 314 Query: 302 TWAPNSVTWTGNNRTHMVRVP-GPGRFELRLPDGAVNPYLLQAIIIAAGLSGVRSKADPG 360 +WAP ++ NNRT+ VR+P G GRFE R DGAVNPYL +++AAGL G+R K DPG Sbjct: 315 SWAPVFNSFGSNNRTNSVRIPLGGGRFENRNADGAVNPYLAATLVLAAGLEGIREKLDPG 374 Query: 361 RHYDIDMYKDGHKVTDAPK-------LPLNLLDALREYNRDEELQEALGREFSAAYLKLK 413 + + ++Y +T+A + LP NL DA++ + D +++ LG+ S ++K K Sbjct: 375 KAQEDNLY----DLTEAERTARGIEFLPQNLNDAVQAFADDPFVEKVLGKGLSDEFIKYK 430 Query: 414 QGEWNTYCSQFTEWE 428 + EWN Y + WE Sbjct: 431 RAEWNDYHQTVSAWE 445 Lambda K H 0.319 0.135 0.421 Gapped Lambda K H 0.267 0.0410 0.140 Matrix: BLOSUM62 Gap Penalties: Existence: 11, Extension: 1 Number of Sequences: 1 Number of Hits to DB: 567 Number of extensions: 25 Number of successful extensions: 6 Number of sequences better than 1.0e-02: 1 Number of HSP's gapped: 1 Number of HSP's successfully gapped: 1 Length of query: 435 Length of database: 453 Length adjustment: 32 Effective length of query: 403 Effective length of database: 421 Effective search space: 169663 Effective search space used: 169663 Neighboring words threshold: 11 Window for multiple hits: 40 X1: 16 ( 7.4 bits) X2: 38 (14.6 bits) X3: 64 (24.7 bits) S1: 41 (21.8 bits) S2: 51 (24.3 bits)
Align candidate WP_019556640.1 F612_RS0104905 (type III glutamate--ammonia ligase)
to HMM TIGR03105 (glnT: glutamine synthetase, type III (EC 6.3.1.2))
# hmmsearch :: search profile(s) against a sequence database # HMMER 3.3.1 (Jul 2020); http://hmmer.org/ # Copyright (C) 2020 Howard Hughes Medical Institute. # Freely distributed under the BSD open source license. # - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - # query HMM file: ../tmp/path.aa/TIGR03105.hmm # target sequence database: /tmp/gapView.3819803.genome.faa # - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - Query: TIGR03105 [M=435] Accession: TIGR03105 Description: gln_synth_III: glutamine synthetase, type III Scores for complete sequences (score includes all domains): --- full sequence --- --- best 1 domain --- -#dom- E-value score bias E-value score bias exp N Sequence Description ------- ------ ----- ------- ------ ----- ---- -- -------- ----------- 1.6e-203 662.0 0.0 1.8e-203 661.8 0.0 1.0 1 NCBI__GCF_000381085.1:WP_019556640.1 Domain annotation for each sequence (and alignments): >> NCBI__GCF_000381085.1:WP_019556640.1 # score bias c-Evalue i-Evalue hmmfrom hmm to alifrom ali to envfrom env to acc --- ------ ----- --------- --------- ------- ------- ------- ------- ------- ------- ---- 1 ! 661.8 0.0 1.8e-203 1.8e-203 2 434 .. 11 450 .. 10 451 .. 0.98 Alignments for each domain: == domain 1 score: 661.8 bits; conditional E-value: 1.8e-203 TIGR03105 2 kklleekgvkyvlaafvdllGvakaklvPvealdalakegagfaGfavsglglePadadllavpdldsliqlP 74 ++ l++kgvky+l a+vd++G++k+k+vP+++ +++k+++ ++G+av+glg++P+++++++vpdl+sliqlP NCBI__GCF_000381085.1:WP_019556640.1 11 QADLKAKGVKYCLGAYVDIHGIPKGKFVPIDHFPQMVKGSELYTGYAVDGLGQKPNEDEIASVPDLNSLIQLP 83 567899******************************************************************* PP TIGR03105 75 wkpevawvaadlvvegkpvelapRvvlkkllaeaaekgftlktGveceffllrreedgklsvaDkaDklakpc 147 w+pevaw+aad++++g+p+++++Rv+lkk+laeaae+gf +++G+ece+f++++e+dg+ls++Dk+D+l+kpc NCBI__GCF_000381085.1:WP_019556640.1 84 WQPEVAWMAADNTLHGEPYDINTRVALKKVLAEAAEMGFGFNLGIECELFVVKEEADGSLSIPDKNDNLTKPC 156 ************************************************************************* PP TIGR03105 148 YDqralmrrydvleeisealnelGwdlYqiDheDanGqfelnfeyaDalttaDrvaffkylvkeiaeeeglla 220 YD++++m+r+++++++++++ +lGwdlY+ DheDanGq+e++f+y+Dalt++Dr++ff+y++k++a+eeglla NCBI__GCF_000381085.1:WP_019556640.1 157 YDVSSFMNRFTWIDKMATTIDDLGWDLYSLDHEDANGQYEFDFKYSDALTMCDRFIFFRYMAKHYAAEEGLLA 229 ************************************************************************* PP TIGR03105 221 tfmPkPfadrtGnGlhlhlslldedg.knlfaddad..eeglglsklayhfiaGilkhakaLaallaPtvnsY 290 t+mPkPfad+tGnG+h+++sl+d ++ +nlf+ d++ ++glgl++++yhfiaG+lkh++aL+a+++PtvnsY NCBI__GCF_000381085.1:WP_019556640.1 230 TMMPKPFADKTGNGAHFNMSLFDLESkENLFEYDPKddPRGLGLTEIGYHFIAGVLKHGPALCAVFSPTVNSY 302 ***********************66659***98876569********************************** PP TIGR03105 291 kRlvakrtlsgatWaPalisyggnnRthmvRiP.dagRlelRlaDgaanpYlvsaavlaaGLdGierkldpgk 362 kRlv+++ +++++WaP+++s+g+nnRt++vRiP ++gR+e R+aDga+npYl++++vlaaGL+Gi++kldpgk NCBI__GCF_000381085.1:WP_019556640.1 303 KRLVRQGDMATFSWAPVFNSFGSNNRTNSVRIPlGGGRFENRNADGAVNPYLAATLVLAAGLEGIREKLDPGK 375 *********************************99************************************** PP TIGR03105 363 rkdenlya...eelaekgvetLPqtLlealraleadelleealGkelveeflklkreeweeyhrtvsdWeidr 432 ++++nly+ +e++++g+e+LPq+L++a++a+++d+++e++lGk+l++ef+k+kr ew++yh+tvs+Wei+r NCBI__GCF_000381085.1:WP_019556640.1 376 AQEDNLYDlteAERTARGIEFLPQNLNDAVQAFADDPFVEKVLGKGLSDEFIKYKRAEWNDYHQTVSAWEIKR 448 *******9998899*********************************************************** PP TIGR03105 433 yl 434 y+ NCBI__GCF_000381085.1:WP_019556640.1 449 YS 450 97 PP Internal pipeline statistics summary: ------------------------------------- Query model(s): 1 (435 nodes) Target sequences: 1 (453 residues searched) Passed MSV filter: 1 (1); expected 0.0 (0.02) Passed bias filter: 1 (1); expected 0.0 (0.02) Passed Vit filter: 1 (1); expected 0.0 (0.001) Passed Fwd filter: 1 (1); expected 0.0 (1e-05) Initial search space (Z): 1 [actual number of targets] Domain search space (domZ): 1 [number of targets reported over threshold] # CPU time: 0.01u 0.01s 00:00:00.02 Elapsed: 00:00:00.01 # Mc/sec: 17.68 // [ok]
This GapMind analysis is from Jul 25 2024. The underlying query database was built on Jul 25 2024.
Each pathway is defined by a set of rules based on individual steps or genes. Candidates for each step are identified by using ublast (a fast alternative to protein BLAST) against a database of manually-curated proteins (most of which are experimentally characterized) or by using HMMer with enzyme models (usually from TIGRFam). Ublast hits may be split across two different proteins.
A candidate for a step is "high confidence" if either:
Otherwise, a candidate is "medium confidence" if either:
Other blast hits with at least 50% coverage are "low confidence."
Steps with no high- or medium-confidence candidates may be considered "gaps." For the typical bacterium that can make all 20 amino acids, there are 1-2 gaps in amino acid biosynthesis pathways. For diverse bacteria and archaea that can utilize a carbon source, there is a complete high-confidence catabolic pathway (including a transporter) just 38% of the time, and there is a complete medium-confidence pathway 63% of the time. Gaps may be due to:
GapMind relies on the predicted proteins in the genome and does not search the six-frame translation. In most cases, you can search the six-frame translation by clicking on links to Curated BLAST for each step definition (in the per-step page).
For more information, see:
If you notice any errors or omissions in the step descriptions, or any questionable results, please let us know
by Morgan Price, Arkin group, Lawrence Berkeley National Laboratory